Tafamidis: A Review in Transthyretin Amyloid Cardiomyopathy.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 113, doi. 10.1007/s40256-020-00461-7
- By:
- Publication type:
- Article
Works matching IS 11753277 AND DT 2021 AND VI 21 AND IP 1
Results: 11
1
2
Comparative Effectiveness and Costs of Enoxaparin Monotherapy Versus Unfractionated Heparin Monotherapy in Treating Acute Coronary Syndrome.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 93, doi. 10.1007/s40256-020-00419-9
- By:
- Publication type:
- Article
3
Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 73, doi. 10.1007/s40256-020-00416-y
- By:
- Publication type:
- Article
4
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 21, doi. 10.1007/s40256-020-00414-0
- By:
- Publication type:
- Article
5
PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 83, doi. 10.1007/s40256-020-00411-3
- By:
- Publication type:
- Article
6
Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 35, doi. 10.1007/s40256-020-00410-4
- By:
- Publication type:
- Article
7
Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 63, doi. 10.1007/s40256-020-00409-x
- By:
- Publication type:
- Article
8
Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 1, doi. 10.1007/s40256-020-00408-y
- By:
- Publication type:
- Article
9
The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 51, doi. 10.1007/s40256-020-00407-z
- By:
- Publication type:
- Article
10
Association Between Statin Use, Intensity and Acute Liver Injury in Human Immunodeficiency Virus, Hepatitis C Virus, and Uninfected US Veterans.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 103, doi. 10.1007/s40256-020-00404-2
- By:
- Publication type:
- Article
11
Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 11, doi. 10.1007/s40256-020-00403-3
- By:
- Publication type:
- Article